ReNeuron Group plc (RNUGF)

USD 0.0

(0.0%)

Long Term Debt Summary of ReNeuron Group plc

  • ReNeuron Group plc's latest annual long term debt in 2023 was 268 Thousand GBP , down -35.58% from previous year.
  • ReNeuron Group plc's latest quarterly long term debt in 2024 Q1 was 189 Thousand GBP , down 0.0% from previous quarter.
  • ReNeuron Group plc reported annual long term debt of 416 Thousand GBP in 2022, down -25.98% from previous year.
  • ReNeuron Group plc reported annual long term debt of 562 Thousand GBP in 2021, down -20.51% from previous year.
  • ReNeuron Group plc reported quarterly long term debt of 189 Thousand GBP for 2024 Q2, down 0.0% from previous quarter.
  • ReNeuron Group plc reported quarterly long term debt of 345 Thousand GBP for 2023 Q1, down -17.07% from previous quarter.

Annual Long Term Debt Chart of ReNeuron Group plc (2023 - 2003)

Historical Annual Long Term Debt of ReNeuron Group plc (2023 - 2003)

Year Long Term Debt Long Term Debt Growth
2023 268 Thousand GBP -35.58%
2022 416 Thousand GBP -25.98%
2021 562 Thousand GBP -20.51%
2020 707 Thousand GBP -18.17%
2019 864 Thousand GBP -10.74%
2018 968 Thousand GBP 96700.0%
2017 1000.00 GBP 0.0%
2016 - GBP -100.0%
2015 1000.00 GBP -50.0%
2014 2000.00 GBP 0.0%
2013 - GBP 0.0%
2012 - GBP -100.0%
2011 10 Thousand GBP -47.37%
2010 19 Thousand GBP -99.09%
2009 2.08 Million GBP 0.0%
2008 - GBP 0.0%
2007 - GBP 0.0%
2006 - GBP 0.0%
2005 - GBP 0.0%
2004 - GBP 0.0%
2003 - GBP 0.0%

Peer Long Term Debt Comparison of ReNeuron Group plc

Name Long Term Debt Long Term Debt Difference
Capstone Therapeutics Corp. 8.26 Million USD 96.757%
Skye Bioscience, Inc. 171.23 Thousand USD -56.515%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 84.734%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -235.0%
Adynxx, Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -0.89%
CSL Limited 11.23 Billion USD 99.998%
Evofem Biosciences, Inc. 8000.00 USD -3250.0%
Arch Therapeutics, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -79.128%
Northwest Biotherapeutics, Inc. 20.31 Million USD 98.681%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 98.718%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -357.01%
Mesoblast Limited 100.29 Million USD 99.733%
Marizyme, Inc. 667.12 Thousand USD 59.828%
Genus plc 228.2 Million USD 99.883%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.839%
Therapeutic Solutions International, Inc. 5512.00 USD -4762.119%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 87.873%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 80.897%
IMV Inc. 27.39 Million USD 99.022%
AXIM Biotechnologies, Inc. 5.42 Million USD 95.061%
MultiCell Technologies, Inc. 36.43 USD -735557.425%
ONE Bio Corp. 592.19 Thousand USD 54.745%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.518%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 87.96%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 78.182%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 51.676%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -959.33%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 85.883%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 16.77%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -78.667%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -63.211%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 98.255%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -5914.363%
Genscript Biotech Corporation 287.12 Million USD 99.907%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -112.19%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -16.882%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -16.678%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -25087.97%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -79.128%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -90.071%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 96.573%
SYBLEU INC 300 Thousand USD 10.667%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 27.381%
International Stem Cell Corporation 445 Thousand USD 39.775%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 96.712%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 41.357%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 76.916%
PureTech Health plc 18.25 Million USD 98.532%
Coeptis Therapeutics, Inc. 150 Thousand USD -78.667%
IXICO plc 275 Thousand USD 2.545%
IntelGenx Technologies Corp. 11.83 Million USD 97.736%
Gelesis Holdings, Inc. 26.3 Million USD 98.981%
CSL Limited 11.23 Billion USD 99.998%
Cellectis S.A. 36.21 Million USD 99.26%